HQ Function

Served as the central hub for Aerie's corporate operations, research and development leadership, and strategic decision-making prior to its acquisition by Alcon.

Notable Features:

The headquarters was situated in a modern office park environment, facilitating collaboration and providing access to the rich talent pool and life sciences ecosystem of the Research Triangle Park.

Work Culture:

Aerie was recognized for its innovative, science-driven, and fast-paced environment. The culture was focused on a mission to develop and deliver novel ophthalmic therapies, with employees often described as passionate and dedicated to addressing unmet medical needs in eye care.

HQ Significance:

The Durham headquarters was pivotal during Aerie's transition from a development-stage company to a commercial entity with FDA-approved products, significantly impacting the glaucoma treatment landscape. It represented the culmination of its R&D efforts and commercial launch preparations.

Values Reflected in HQ: The choice of Research Triangle Park for its headquarters underscored Aerie's commitment to innovation, scientific excellence, and collaboration within the broader pharmaceutical and biotechnology community.

Location:

Prior to its acquisition by Alcon, Aerie Pharmaceuticals was building its global presence. While its initial commercial focus was the United States, it established a significant manufacturing facility in Athlone, Ireland, to support global supply needs. The company was also actively exploring regulatory and commercial pathways in other key international markets, including Europe and Japan, for its innovative ophthalmic therapies. Its research and development activities, while primarily US-based, had global implications for advancing eye care.

Street Address:

4301 Emperor Boulevard, Suite 400

City:

Durham

State/Province:

North Carolina

Country:

USA